1. Home
  2. Browse
  3. Cardiology
  4. Dyslipidemia

Dyslipidemia

241 - 255 of 278 Results
Sort Results:
Guideline: Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity June 2008
Guideline: Type 2 Diabetes in Children and Adolescents June 2008
Guideline: Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents June 2008
Patient Education: What You Should Know About Ezetrol/Zocor and the ENHANCE Study May 2008
Guideline: Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults and Implications of Recent Clinical Trials for the NCEP Guidelines May 2008
Guideline: Canadian Cardiovascular Society Recommendations for the Diagnosis and Treatment of Dyslipidemia and Prevention of Cardiovascular Disease May 2008
Chart: Cholesterol-lowering Drugs May 2008
Commentary: Does Ezetimibe ENHANCE lipid therapy? More information from the ENHANCE trial May 2008
Guideline: Working Group on Hypercholesterolemia Recommendations for the Management of Dyslipidemia and Prevention of Cardiovascular Disease (2003 Update) May 2008
Article: The Ezetrol controversy exposes shortcomings of surrogate endpoints May 2008
Article: whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients March 2008
Guideline: Recommendations for the Diagnosis and Treatment of Dyslipidemia and Prevention of Cardiovascular Disease February 2008
Commentary: Does Ezetimibe ENHANCE Lipid Therapy? February 2008
Other: For updated information on this topic, please see Detail-Document #240513 February 2008
Patient Education: What You Should Know About Ezetrol/Zocor and the ENHANCE Study February 2008